Skip Navigation

NHLBI In The News

Filter News Mentions

April 20, 2017 : The New England Journal of Medicine

A study conducted by NHLBI researchers found that the drug eltrombopag improves the response to treatment in patients with severe aplastic anemia. “Eltrombopag plus standard immunosuppressive therapy appeared to increase the overall response rate and substantially increase the frequency, speed and robustness of hematologic recovery in patients with SAA compared to historical controls,” said NHLBI researcher and the study’s lead author, Danielle Townsley, MD. The findings appear in the The New England Journal of Medicine.

Healio: Eltrombopag shows promise as first treatment for severe aplastic anemia

PharmaTimes: Data back first-line use of Novartis’ eltrombopag in SAA

Hematology Times: Combo improves response rates in treatment-naïve SAA

RareDR: Should Second-line Aplastic Anemia Drug Be a First-line Option?

GlobeNewswire: NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia

April 19, 2017 : Medical News Today

Researchers are reporting new insights into how the electrical ‘power grids’ of interconnected mitochondria inside heart muscle cells work.  They showed that this mitochondrial network contains several smaller subnetworks that act like a circuit breaker, limiting the impact of ‘faulty’ mitochondria in order to protect the heart from damage. The discovery may lead to a better understanding of heart disease and other conditions. Their study, published in Cell Reports, was partly funded by the NHLBI.

Medical Xpress: Researchers discover mitochondrial 'circuit breaker' that protects heart from damage

Muscular Dystrophy News Today: Heart, Other Muscles’ Response to Energy Malfunctions Has Implications for MS

Mitochondrial Disease News: How mitochondria prevent spread of heart or skeletal muscle damage

EurekAlert: Researchers discover mitochondrial 'circuit breaker' that protects heart from damage

April 19, 2017 : JAMA Cardiology

Men and African Americans are more likely to transition from ideal to elevated blood pressure, or hypertension, at a younger age than the general population, according to an NHLBI-funded study published in JAMA Cardiology. According to the researchers, the findings call for “primordial prevention in childhood and early adulthood” instead of paying attention to blood pressure as a risk factor to be treated once people become hypertensive.

April 11, 2017 : JAMA

Researchers funded through the NHLBI’s Atherosclerosis Risk in Communities (ARIC) Study found that midlife risk factors for vascular disease, such as obesity, high blood pressure, diabetes, high cholesterol and smoking, were linked, later in life, with higher levels of brain amyloid, the protein fragments associated with Alzheimer’s disease. The study was published in JAMA.

Reuters: Risk factors for heart disease and stroke also tied to Alzheimer’s

Medical News Today: Link between vascular disease and Alzheimer's strengthened

Medpage Today: Midlife Vascular Risk Factors Tied to Brain Amyloid

EurekAlert: Findings support role of vascular disease in development of Alzheimer's disease

April 7, 2017 : JAMA: The Journal of the American Medical Association

This year marks the 20th anniversary of the publication showing the blood pressure–lowering effects of the Dietary Approaches to Stop Hypertension (DASH) diet. A commentary in JAMA: The Journal of the American Medical Association discusses the importance of the diet and the benefits that wider adoption will have for public health. In January, for the seventh year in a row, U.S. News & World Report ranked the NIH-developed DASH Diet “best overall” diet.

Washington Post: The DASH diet is proven to work. Why hasn’t it caught on?

Washingtonian Magazine: America’s Number One Ranked Healthy Diet Has Nothing to Do with Losing Weight

CBN News: How the DASH Diet Can Spare You from 'The Silent Killer'

India Times: Looking For That One Diet Which Can Keep You Healthy For Life? Look No Further Than The DASH Diet

April 5, 2017 : The New England Journal of Medicine

A newly discovered syndrome, dubbed the “GPIHBP1 autoantibody syndrome,” leads to the production of autoantibodies that cause high levels of triglycerides in the blood. The NHLBI funded study appears in The New England Journal of Medicine. “The researchers have not only discovered a new disease, but their findings have suggested that the disease is treatable,” said Dr. Michelle Olive, from the NHLBI.

Physician's Briefing: Autoantibodies to GPIHBP1 Identified in Chylomicronemia

My Science: New cause of high plasma triglycerides

HealthCanal: Autoantibodies, which attack people’s own proteins, cause some cases of hypertriglyceridemia

Newswise: UCLA researchers discover a new cause of high plasma triglycerides

Health Medicine Network: Researchers discover a new cause of high plasma triglycerides

News Medical: ULCA scientists discover how autoantibodies cause some cases of severe hypertriglyceridemia

MedIndia: Autoantibodies - New Cause For High Plasma Triglycerides Identified

More coverage

April 3, 2017 : Proceedings of the National Academy of Sciences

A team of researchers is reporting that they have identified the location of an elusive ‘permeability barrier’ within the wall of the artery and note that this barrier that plays a key role in normal and disease processes.   This barrier provides a seal against water movement across the arterial wall even at high pressures. This seal permits the high-pressure artery to deliver blood throughout the body without leaks.   Defective arterial wall permeability to water is altered in many diseases, including diabetes, atherosclerosis, and high blood pressure.  Using high tech imaging tools, the researchers directly mapped the water permeability to a specific membrane of the arterial wall. A better understanding of this barrier could lead to improved understanding and treatment of disease as well as new potential genetic markers of vascular disease vulnerability, the researchers say.  The study, which appeared online in Proceedings of the National Academy of Sciences (link is external), is funded by NHLBI.  

PNAS Editorial: Crossing the arterial wall with CARS

April 3, 2017 : Nature Genetics

Structural variants (SVs), also known as structural variations, are an important source of human genetic diversity, but their contribution to traits, disease and gene regulation remains unclear. A study by NHLBI funded researchers found that SVs they have a greater influence in gene expression than previously thought.

GenomeWeb: Structural Variants Impact Gene Expression More Than Previously Thought

More Coverage

March 29, 2017 : TCTMD

A study by NHLBI researchers shows that requests to use the Institute’s data repository are increasing rapidly, and their primary objective is to answer new research questions. “Requesting data for the a priori purpose of reanalysis or verification of original findings was rare,” said study author Sean Coady, MS, from the NHLBI. The findings appeared in The New England Journal of Medicine.  Additional coverage March 31, 2017 in Medpage Today.

March 29, 2017 : Journal of the American Heart Association

Gum disease and tooth loss may be associated with a higher risk of death in postmenopausal women but not increased cardiovascular disease risk, according to an NHLBI funded study published in the Journal of the American Heart Association.

The New York Times: Healthy Gums May Signal a Longer Life

Medscape: Gum Disease, Tooth Loss Predicts Increased Mortality in Older Women: WHI Analysis

CNN: Older women with gum disease face higher risk of early death, study says

More coverage

Page 7 of 91


Subscribe to NHLBI In The News